Much excitement surrounding the industry this month. The recent Adult Stem Cell Conference at the Vatican has once again sparked debate, and a new IVF procedure gaining support in the UK will continue to fuel the fire.
This week we feature two pieces from our Scientific Editorial Team tackling this and similar subjects. One explores the potential for stem cells to prevent mitochondrial disease at fertilization; the second introduces you to microRNA.
We have also published a special piece looking at SanuWave Health and InVivo Therapeutics as case studies for alternative regulatory paths to 510(k). Finally, we feature two candid radio interviews with life sciences company executives.
Remember to register for the upcoming OneMedForumNY 2013, June 26-27 at the Metropolitan Club at the base of Central Park. Investors may be eligible to receive a complimentary ticket. To apply for a complimentary ticket, fill out our Attendee Survey, and we will contact you with further instructions.